<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Guide to low-dose naltrexone (LDN) for chronic pain - mechanism, evidence, conditions treated, and what patients should know.">
    <meta name="keywords" content="low dose naltrexone, LDN, naltrexone pain, LDN fibromyalgia, naltrexone chronic pain">
    <title>Low-Dose Naltrexone (LDN) | ChronicSoreness</title>
    <link rel="stylesheet" href="../css/styles.css">
</head>
<body>
    <header class="header"><nav class="nav-container"><div class="logo"><a href="../index.html"><span class="logo-icon">ðŸ’œ</span><span class="logo-text"><strong>Chronic</strong>Soreness</span></a></div><button class="mobile-menu-toggle" aria-label="Toggle menu"><span class="hamburger"></span></button><ul class="nav-menu"><li><a href="../conditions.html">Conditions</a></li><li><a href="../treatments.html">Treatments</a></li><li><a href="../medications.html">Medications</a></li><li><a href="../exercise.html">Exercise</a></li><li><a href="../nutrition.html">Nutrition</a></li><li><a href="../mental-health.html">Mental Health</a></li></ul></nav></header>
    <main id="main-content">
        <article class="page-header"><h1>Low-Dose Naltrexone (LDN)</h1><p>An emerging pain treatment option</p></article>
        <section class="content-section">
            <div class="container">
                <h2>What Is Low-Dose Naltrexone?</h2>
                <p>Low-dose naltrexone (LDN) refers to naltrexone used at doses of 1-5mg, much lower than the standard 50mg dose used for addiction. At these low doses, it's thought to have different effects that may help with pain and inflammation. It's an off-label use gaining interest for chronic pain conditions.<sup>1</sup></p>

                <h2>How It May Work<sup>2</sup></h2>
                <ul>
                    <li>Modulates the immune system</li>
                    <li>Reduces glial cell activation in nervous system</li>
                    <li>May decrease inflammation</li>
                    <li>Temporarily blocks opioid receptors</li>
                    <li>May increase endorphin production (rebound effect)</li>
                </ul>

                <h2>Conditions Being Studied</h2>
                <ul>
                    <li>Fibromyalgia (most research)</li>
                    <li>Chronic fatigue syndrome</li>
                    <li>Multiple sclerosis</li>
                    <li>Crohn's disease</li>
                    <li>Complex regional pain syndrome</li>
                    <li>Rheumatoid arthritis</li>
                </ul>

                <h2>Evidence<sup>3</sup></h2>
                <ul>
                    <li>Small studies show promise for fibromyalgia</li>
                    <li>Some benefit seen in autoimmune conditions</li>
                    <li>Research is still limited</li>
                    <li>Large clinical trials needed</li>
                    <li>Not FDA-approved for pain</li>
                </ul>

                <h2>Dosing</h2>
                <ul>
                    <li>Typically 1.5-4.5mg daily</li>
                    <li>Usually taken at bedtime</li>
                    <li>Often started low and increased gradually</li>
                    <li>Requires compounding pharmacy</li>
                    <li>Regular naltrexone tablets are 50mg</li>
                </ul>

                <h2>Side Effects</h2>
                <ul>
                    <li>Generally well-tolerated</li>
                    <li>Vivid dreams (common)</li>
                    <li>Sleep disturbances (usually temporary)</li>
                    <li>Nausea</li>
                    <li>Headache</li>
                    <li>Most side effects diminish over time</li>
                </ul>

                <h2>Important Considerations</h2>
                <ul>
                    <li><strong>Cannot take with opioid medications</strong></li>
                    <li>Must stop opioids before starting LDN</li>
                    <li>Not covered by most insurance</li>
                    <li>Requires compounding (cost varies)</li>
                    <li>Many doctors unfamiliar with LDN</li>
                </ul>

                <h2>Finding LDN</h2>
                <ul>
                    <li>Requires prescription</li>
                    <li>Need compounding pharmacy</li>
                    <li>Some integrative medicine doctors prescribe</li>
                    <li>Ask if your doctor is familiar with LDN research</li>
                </ul>

                <h2>References</h2>
                <ol>
                    <li>Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. <em>Clin Rheumatol</em>. 2014;33(4):451-459.</li>
                    <li>Younger J, Mackey S. Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study. <em>Pain Med</em>. 2009;10(4):663-672.</li>
                    <li>Patten DK, Schultz BG, Berlau DJ. The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn's disease, and other chronic pain disorders. <em>Pharmacotherapy</em>. 2018;38(3):382-389.</li>
                </ol>
            </div>
        </section>
    </main>
    <footer class="footer"><div class="container"><p class="disclaimer">The information provided is for educational purposes only and is not medical advice.</p><p class="copyright">Â© 2024 ChronicSoreness. All rights reserved.</p></div></footer>
    <script src="../js/main.js"></script>
</body>
</html>
